Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT).
暂无分享,去创建一个
R. Greil | M. Fridrik | W. Eisterer | J. Thaler | A. Zabernigg | B. Mayrbäurl | E. Woell | B. Grünberger | G. Russ